The invention provides modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.
RELATED APPLICATIONS
This application is a continuation of International Patent Application No: PCT/US2004/009906, filed Mar. 29, 2004 designating the U.S. and published in English on Oct. 14, 2004 as WO 2004/087201, which claims the benefit of U.S. Provisional Patent Application No. 60/459,175, filed Mar. 28, 2003, both of with are hereby expressly incorporated by reference in their entireties.
